A woman filed a lawsuit in a federal court in Houston against Death Row Records after never receiving the $100 million that ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...